Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis

Fig. 3

The result of the forest plot analysis for the total effective rate and cough recurrence rate between the montelukast (Mon) + fluticasone propionate (Flu) group and the Flu group. A The result of the forest plot analysis for total effective rate between the Mon + Flu group and the Flu group. A fixed-effect model was used since the I2=15%. The pooled results showed that Flu + Mon significantly improved the total efficacy rate. B The result of the forest plot analysis for cough recurrence rate between the Mon + Flu group and the Flu group. A fixed-effect model was used since the I2=0%. The pooled results showed that Flu + Mon significantly reduced cough recurrence

Back to article page